Abstract
Due to the extensive application of porphyrins today, this paper aims to present a short review on the synthesis of the first and principal methodologies and compares their yields and reaction conditions. It should be noted that these methodologies were the precursors to the development of numerous syntheses of porphyrins.
Keywords: Porphyrins, biological activity
Mini-Reviews in Organic Chemistry
Title:Synthesis and Biological Activity of Porphyrins
Volume: 10 Issue: 1
Author(s): Daniela P. V. Souza, Marco Antonio G. B. Gomes, Paula S. Goncalves, Roberto P. Santos, Edmilson J. Maria and Carlos Roberto R. Matos
Affiliation:
Keywords: Porphyrins, biological activity
Abstract: Due to the extensive application of porphyrins today, this paper aims to present a short review on the synthesis of the first and principal methodologies and compares their yields and reaction conditions. It should be noted that these methodologies were the precursors to the development of numerous syntheses of porphyrins.
Export Options
About this article
Cite this article as:
P. V. Souza Daniela, Antonio G. B. Gomes Marco, S. Goncalves Paula, P. Santos Roberto, J. Maria Edmilson and Roberto R. Matos Carlos, Synthesis and Biological Activity of Porphyrins, Mini-Reviews in Organic Chemistry 2013; 10 (1) . https://dx.doi.org/10.2174/1570193X11310010008
DOI https://dx.doi.org/10.2174/1570193X11310010008 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model
Current Molecular Medicine Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry
Current Medical Imaging Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate
Current Drug Safety Nano-Tetrandrine Efficiently Inhibits the Proliferation and Induces the Apoptosis of Hep2 Cells through a Mitochondrial Signaling Pathway
Current Signal Transduction Therapy Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy
Current Topics in Medicinal Chemistry Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon
Anti-Cancer Agents in Medicinal Chemistry Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid
Anti-Cancer Agents in Medicinal Chemistry Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia
Current Vascular Pharmacology Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
Recent Patents on Anti-Cancer Drug Discovery Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Recent Progress on Apoptotic Activity of Triazoles
Current Drug Targets DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery